ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,074,144 | -20.4% | 160,800 | 0.0% | 0.10% | -6.4% |
Q2 2023 | $1,349,112 | -15.5% | 160,800 | 0.0% | 0.11% | -17.4% |
Q1 2023 | $1,596,744 | +42.7% | 160,800 | 0.0% | 0.13% | +38.9% |
Q4 2022 | $1,119,168 | +30.3% | 160,800 | 0.0% | 0.10% | +39.7% |
Q3 2022 | $859,000 | +33.8% | 160,800 | 0.0% | 0.07% | +21.4% |
Q2 2022 | $642,000 | -10.2% | 160,800 | 0.0% | 0.06% | +1.8% |
Q1 2022 | $715,000 | +11.2% | 160,800 | 0.0% | 0.06% | +34.1% |
Q4 2021 | $643,000 | -54.5% | 160,800 | 0.0% | 0.04% | -51.8% |
Q3 2021 | $1,412,000 | -22.5% | 160,800 | 0.0% | 0.08% | -15.0% |
Q2 2021 | $1,822,000 | -4.6% | 160,800 | 0.0% | 0.10% | -8.3% |
Q1 2021 | $1,910,000 | +73.2% | 160,800 | 0.0% | 0.11% | +87.9% |
Q4 2020 | $1,103,000 | +26.2% | 160,800 | +36.3% | 0.06% | +20.8% |
Q3 2020 | $874,000 | +185.6% | 118,000 | +60.5% | 0.05% | +166.7% |
Q2 2020 | $306,000 | +68.1% | 73,500 | 0.0% | 0.02% | +20.0% |
Q1 2020 | $182,000 | -57.4% | 73,500 | 0.0% | 0.02% | -37.5% |
Q4 2019 | $427,000 | +10.3% | 73,500 | 0.0% | 0.02% | -7.7% |
Q3 2019 | $387,000 | -12.2% | 73,500 | 0.0% | 0.03% | +23.8% |
Q2 2019 | $441,000 | – | 73,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |